Abstract
Food allergy is an increasingly prevalent disorder with potentially life-threatening complications that requires life-altering changes in dietary habits and psychosocial interactions. The standard of care presently includes strict dietary elimination of the implicated allergen and ready access to injectable epinephrine; however, no active, definitive therapeutic options exist for food-allergic patients. Although the detailed immunologic mechanisms underlying the development of food allergy are still being fully defined, food allergy appears to be the direct result of a breakdown in oral tolerance. Thus, current therapeutic approaches to food allergy are focused on modulating the immunologic response to food proteins to promote induction of oral tolerance. In this review, we examine gastrointestinal mucosal immunity and the mechanisms of oral tolerance, as well as the breakdown in oral tolerance that promotes food allergy, and we also explore novel therapeutic interventions for treatment of food allergy.
Similar content being viewed by others
References and Recommended Reading
Sicherer SH, Sampson HA: 9. Food allergy. J Allergy Clin Immunol 2006, 117(2 Suppl Mini-Primer):S470–S475.
Sicherer SH, Sampson HA: Food allergy: recent advances in pathophysiology and treatment. Annu Rev Med 2008 Aug 19 (Epub ahead of print).
Sicherer SH, Sampson HA: Peanut allergy: emerging concepts and approaches for an apparent epidemic. J Allergy Clin Immunol 2007, 120:491–503; quiz 504–505.
Yocum MW, Butterfield JH, Klein JS, et al.: Epidemiology of anaphylaxis in Olmsted County: a population-based study. J Allergy Clin Immunol 1999, 104:452–456.
Clark S, Bock SA, Gaeta TJ, et al.: Multicenter study of emergency department visits for food allergies. J Allergy Clin Immunol 2004, 113:347–352.
Bock SA, Muñoz-Furlong A, Sampson HA: Further fatalities caused by anaphylactic reactions to food, 2001–2006. J Allergy Clin Immunol 2007, 119:1016–1018.
Joshi P, Mofidi S, Sicherer SH: Interpretation of commercial food ingredient labels by parents of food-allergic children. J Allergy Clin Immunol 2002, 109:1019–1021.
Vierk K, Falci K, Wolyniak C, Klontz KC: Recalls of foods containing undeclared allergens reported to the US Food and Drug Administration, fiscal year 1999. J Allergy Clin Immunol 2002, 109:1022–1026.
Altschul AS, Scherrer DL, Muñoz-Furlong A, Sicherer SH: Manufacturing and labeling issues for commercial products: relevance to food allergy. J Allergy Clin Immunol 2001, 108:468.
Sicherer SH, Burks AW, Sampson HA: Clinical features of acute allergic reactions to peanut and tree nuts in children. Pediatrics 1998, 102:e6.
Cohen BL, Noone S, Muñoz-Furlong A, Sicherer SH: Development of a questionnaire to measure quality of life in families with a child with food allergy. J Allergy Clin Immunol 2004, 114:1159–1163.
Sicherer SH, Noone SA, Muñoz-Furlong A: The impact of childhood food allergy on quality of life. Ann Allergy Asthma Immunol 2001, 87:461–464.
Bollinger ME, Dahlquist LM, Mudd K, et al.: The impact of food allergy on the daily activities of children and their families. Ann Allergy Asthma Immunol 2006, 96:415–421.
Chehade M, Mayer L: Oral tolerance and its relation to food hypersensitivities. J Allergy Clin Immunol 2005, 115:3–12; quiz 13.
Mayer L: Mucosal immunity. Pediatrics 2003, 111:1595–1600.
Michael JG: The role of digestive enzymes in orally induced immune tolerance. Immunol Invest 1989, 18:1049–1054.
Barone KS, Reilly MR, Flanagan MP, Michael JG: Abrogation of oral tolerance by feeding encapsulated antigen. Cell Immunol 2000, 199:65–72.
Scott H, Solheim BG, Brandtzaeg P, Thorsby E: HLADR-like antigens in the epithelium of the human small intestine. Scand J Immunol 1980, 12:77–82.
Menezes Jda S, Mucida DS, Cara DC, et al.: Stimulation by food proteins plays a critical role in the maturation of the immune system. Int Immunol 2003, 15:447–455.
Faria AM, Weiner HL: Oral tolerance. Immunol Rev 2005, 206:232–259.
Friedman A, Weiner HL: Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc Natl Acad Sci U S A 1994, 91:6688–6692.
Strobel S, Mowat AM: Oral tolerance and allergic responses to food proteins. Curr Opin Allergy Clin Immunol 2006, 6:207–213.
Lack G: Epidemiologic risks for food allergy. J Allergy Clin Immunol 2008, 121:1331–1336.
Groux H, O’Garra A, Bigler M, et al.: A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997, 389:737–742.
Wakkach A, Fournier N, Brun V, et al.: Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity 2003, 18:605–617.
Chen W, Jin W, Hardegen N, et al.: Conversion of peripheral CD4+CD25-naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003, 198:1875–1886.
Sakaguchi S: Regulatory T cells: key controllers of immunologic self-tolerance. Cell 2000, 101:455–458.
Sakaguchi S: Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004, 22:531–562.
Fontenot JD, Gavin MA, Rudensky AY: Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003, 4:330–336.
Hori S, Nomura T, Sakaguchi S: Control of regulatory T cell development by the transcription factor Foxp3. Science 2003, 299:1057–1061.
Bettelli E, Carrier Y, Gao W, et al.: Reciprocal developmental pathways for the generation of pathogenic effector Th17 and regulatory T cells. Nature 2006, 441:235–238.
Laurence A, Tato CM, Davidson TS, et al.: Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 2007, 26:371–381.
Torgerson TR, Linane A, Moes N, et al.: Severe food allergy as a variant of IPEX syndrome caused by a deletion in a noncoding region of the FOXP3 gene. Gastroenterology 2007, 132:1705–1717.
Beyer K, Castro R, Birnbaum A, et al.: Human milkspecific mucosal lymphocytes of the gastrointestinal tract display a Th2 cytokine profile. J Allergy Clin Immunol 2002, 109:707–713.
Levy Y, Broides A, Segal N, Danon YL: Peanut and tree nut allergy in children: role of peanut snacks in Israel? Allergy 2003, 58:1206–1207.
Francis JN, James LK, Paraskevopoulos G, et al.: Grass pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activity. J Allergy Clin Immunol 2008, 121:1120.e2–1125.e2.
Oppenheimer JJ, Nelson HS, Bock SA, et al.: Treatment of peanut allergy with rush immunotherapy. J Allergy Clin Immunol 1992, 90:256–262.
Nelson HS, Lahr J, Rule R, et al.: Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract. J Allergy Clin Immunol 1997, 99:744–751.
Li XM, Srivastava K, Grishin A, et al.: Persistent protective effect of heat-killed Escherichia coli producing “engineered,” recombinant peanut proteins in a murine model of peanut allergy. J Allergy Clin Immunol 2003, 112:159–167.
Li XM, Srivastava K, Huleatt JW, et al.: Engineered recombinant peanut protein and heat-killed Listeria monocytogenes coadministration protects against peanutinduced anaphylaxis in a murine model. J Immunol 2003, 170:3289–3295.
Enrique E, Pineda F, Malek T, et al.: Sublingual immunotherapy for hazelnut food allergy: a randomized, double-blind, placebo-controlled study with a standardized hazelnut extract. J Allergy Clin Immunol 2005, 116:1073–1079.
Mempel M, Rakoski J, Ring J, Ollert M: Severe anaphylaxis to kiwi fruit: immunologic changes related to successful sublingual allergen immunotherapy. J Allergy Clin Immunol 2003, 111:1406–1409.
Kerzl R, Simonowa A, Ring J, et al.: Life-threatening anaphylaxis to kiwi fruit: protective sublingual allergen immunotherapy effect persists even after discontinuation. J Allergy Clin Immunol 2007, 119:507–508.
Patriarca G, Nucera E, Roncallo C, et al.: Oral desensitizing treatment in food allergy: clinical and immunological results. Aliment Pharmacol Ther 2003, 17:459–465.
Meglio P, Bartone E, Plantamura M, et al.: A protocol for oral desensitization in children with IgE-mediated cow’s milk allergy. Allergy 2004, 59:980–987.
Buchanan AD, Green TD, Jones SM, et al.: Egg oral immunotherapy in nonanaphylactic children with egg allergy. J Allergy Clin Immunol 2007, 119:199–205.
Rolinck-Werninghaus C, Staden U, Mehl A, et al.: Specific oral tolerance induction with food in children: transient or persistent effect on food allergy? Allergy 2005, 60:1320–1322.
Staden U, Rolinck-Werninghaus C, Brewe F, et al.: Specific oral tolerance induction in food allergy in children: efficacy and clinical patterns of reaction. Allergy 2007, 62:1261–1269.
Longo G, Barbi E, Berti I, et al.: Specific oral tolerance induction in children with very severe cow’s milk-induced reactions. J Allergy Clin Immunol 2008, 121:343–347.
Staden U, Blumchen K, Blankenstein N, et al.: Rush oral immunotherapy in children with persistent cow’s milk allergy. J Allergy Clin Immunol 2008, 122:418–419.
Skripak JM, Nash SD, Rowley H, et al.: A randomized, double-blind, placebo-controlled study of milk oral immunotherapy for cow’s milk allergy. J Allergy Clin Immunol 2008, 122:1154–1160.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Scurlock, A.M., Burks, A.W. & Jones, S.M. Oral immunotherapy for food allergy. Curr Allergy Asthma Rep 9, 186–193 (2009). https://doi.org/10.1007/s11882-009-0028-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11882-009-0028-z